Heartburn drugs linked to fatal heart and kidney disease, stomach cancer
A study from researchers at the School of Medicine and Veterans Affairs St. Louis Health Care System has linked long-term use of drugs known as proton pump inhibitors (PPIs) to fatal cases of cardiovascular disease, chronic kidney disease and upper gastrointestinal cancer. The researchers found that such risks increase with the duration of PPI use, even when taken at low doses.
Immune cells determine how fast certain tumors grow
Researchers at the School of Medicine studying brain tumors in mice discovered that tumors grow most rapidly if they can enlist the aid of immune cells. The findings suggest that therapies targeting immune cells could potentially treat some kinds of brain tumors.
$9.5 million aimed at detecting autism earlier in childhood
Researchers at the School of Medicine are leading a multicenter team conducting research to evaluate whether brain imaging might help reveal risk for autism spectrum disorder in early infancy. Previous research suggests such imaging in high-risk children can predict problems in kids as young as 6 months old.
Metcalfe gift supports study of adversity’s effects on children’s brains
A gift from Walter Metcalfe Jr. and his wife, Cynthia, will support the work of School of Medicine child psychiatrist Joan Luby, MD, and her collaborators. The gift was inspired by promising early findings suggesting interventions to address the impact of toxic stress on the long-term behavioral and mental health of children.
Proton therapy for cancer lowers risk of side effects
A new study led by the School of Medicine has found that proton therapy is associated with fewer severe side effects than conventional X-ray radiation therapy for many cancer patients.
What a snapshot image of chikungunya is revealing
School of Medicine researchers have snapped high-resolution pictures of the chikungunya virus latched onto a protein found on the surface of cells in the joints. The findings could accelerate efforts to find new ways to prevent or treat viral arthritis.
Drug-resistant tuberculosis reversed in lab
Mycobacterium tuberculosis cause the most lethal infectious disease in the world. Researchers at the School of Medicine and Umea University in Sweden have found a compound that can prevent and even reverse antibiotic resistance in tuberculosis bacteria.
$5.1 million to target silent cause of heart attacks, strokes
The School of Medicine’s Yongjian Liu has received an Emerging Investigator Award to find ways to detect plaque at risk of shedding fragments that could cause heart attacks or strokes.
Antibiotics may treat endometriosis
Researchers at the School of Medicine have found that treating mice with an antibiotic reduces the size of lesions caused by endometriosis. The researchers are planning a clinical trial to test the strategy in women who have the painful condition.
‘Lessons learned’ from engaging in Africa
Washington University in St. Louis is committed to engaging with its global partners to help address our biggest challenges together. This spirit of collaboration was evident at the inaugural meeting of the Africa initiative, held April 23 on the Danforth Campus.
Older Stories